Defining the unbound target exposure of teicoplanin, Part 2: Dose individualization through population pharmacokinetic modelling

Clinical Microbiology and Infection · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles